Sectors
RCUS
Arcus Biosciences, Inc.
29.28
300 x 23.50
200 x 29.12
bid
ask
+
0.07
0.24%
250 @ 07:30 PM
29.28 +0.00 (0.00%)
| Ytd | 22.87% | |
| 1y | 176.49% |
28.23
day range
29.34
10.55
52 week range
31.73
| Open | 28.89 | Prev Close | 29.21 | Low | 28.23 | High | 29.34 | Mkt Cap | 3.68B |
| Vol | 1.11M | Avg Vol | 1.29M | EPS | -3.95 | P/E | N/A | Forward P/E | -8.76 |
| Beta | 0.81 | Short Ratio | 12.61 | Inst. Own | 74.67% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 28.99 | 200-d Avg | 24.37 | 1yr Est | 38.33 |
| Income Statement | |||
| Total Revenue | 41.00M | ||
| Revenues (USD) | 41.00M | ||
| Gross Profit | 41.00M | ||
| Operating Expenses | 137.00M | ||
| Research and Development Expense | 113.00M | ||
| Selling, General and Administrative Expense | 24.00M | ||
| Operating Income | -96.00M | ||
| Interest Expense | 3.00M | ||
| Net Income | -91.00M | ||
| Net Income Common Stock | -91.00M | ||
| Net Income Common Stock (USD) | -91.00M | ||
| Consolidated Income | -91.00M | ||
| Earnings per Basic Share | -0.72 | ||
| Earnings per Basic Share (USD) | -0.72 | ||
| Earnings per Diluted Share | -0.72 | ||
| Earning Before Interest & Taxes (EBIT) | -88.00M | ||
| Earning Before Interest & Taxes (USD) | -88.00M | ||
| Weighted Average Shares | 126.10M | ||
| Weighted Average Shares Diluted | 126.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 150.00M | ||
| Cash and Equivalents (USD) | 150.00M | ||
| Investments | 625.00M | ||
| Investments Current | 552.00M | ||
| Investments Non-Current | 73.00M | ||
| Trade and Non-Trade Receivables | 36.00M | ||
| Current Assets | 756.00M | ||
| Property, Plant & Equipment Net | 36.00M | ||
| Total Assets | 924.00M | ||
| Total Debt | 101.00M | ||
| Current Liabilities | 198.00M | ||
| Debt Non-Current | 101.00M | ||
| Total Liabilities | 460.00M | ||
| Accumulated Retained Earnings (Deficit) | -1.70B | ||
| Accumulated Other Comprehensive Income | -1000.00K | ||
| Shareholders Equity | 464.00M | ||
| Shareholders Equity (USD) | 464.00M | ||
| Assets Non-Current | 168.00M | ||
| Total Debt (USD) | 101.00M | ||
| Deferred Revenue | 56.00M | ||
| Liabilities Non-Current | 262.00M | ||
| Trade and Non-Trade Payables | 34.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.00M | ||
| Net Cash Flow from Financing | 16.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -51.00M | ||
| Issuance (Purchase) of Equity Shares | 16.00M | ||
| Net Cash Flow from Investing | 52.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 52.00M | ||
| Net Cash Flow from Operations | -119.00M | ||
| Share Based Compensation | 15.00M | ||